Cargando…

Improvement of solubility and yield of recombinant protein expression in E. coli using a two-step system

Overexpression of recombinant proteins in Escherichia coli results in inclusion body formation, and consequently decreased production yield and increased production cost. Co-expression of chaperon systems accompanied by recombinant protein is a general method to increase the production yield. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sadeghian-Rizi, Tahereh, Ebrahimi, Azade, Moazzen, Fatemeh, Yousefian, Hesam, Jahanian-Najafabadi, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827196/ https://www.ncbi.nlm.nih.gov/pubmed/31798656 http://dx.doi.org/10.4103/1735-5362.268200

Ejemplares similares

Evaluation of soluble expression of recombinant granulocyte macrophage stimulating factor (rGM-CSF) by three different E. coli strains
por: Soheili, Sina, et al.
Publicado: (2020)

Association of AIRE Polymorphism and the Susceptibility to Multiple Sclerosis in Iranian Population
por: Sadeghian-Rizi, Tahereh, et al.
Publicado: (2018)

High-yield Production of Granulocyte-macrophage Colony-stimulating Factor in E. coli BL21 (DE3) By an Auto-induction Strategy
por: Malekian, Raziyeh, et al.
Publicado: (2019)

Chaperone-based procedure to increase yields of soluble recombinant proteins produced in E. coli
por: de Marco, Ario, et al.
Publicado: (2007)

Synthesis and evaluation of antimicrobial activity of cyclic imides derived from phthalic and succinic anhydrides
por: Jafari, Elham, et al.
Publicado: (2017)

Cloning, Optimization of Periplasmic Expression and Purification of Recombinant Granulocyte Macrophage-Stimulating Factor in Escherichia coli BL21 (DE3)
por: Taherian, Elham, et al.
Publicado: (2019)

Synthesis and characterization of some novel diaryl urea derivatives bearing quinoxalindione moiety
por: Sadeghian-Rizi, Sedighe, et al.
Publicado: (2018)

Cloning, Soluble Expression and Purification of High Yield Recombinant hGMCSF in Escherichia coli
por: Das, Krishna M.P., et al.
Publicado: (2011)

Biological evaluation, docking and molecular dynamic simulation of some novel diaryl urea derivatives bearing quinoxalindione moiety
por: Sadeghian-Rizi, Sedighe, et al.
Publicado: (2017)

Optimization of the Expression of DT386-BR2 Fusion Protein in Escherichia coli using Response Surface Methodology
por: Shafiee, Fatemeh, et al.
Publicado: (2017)

Preliminary Study on Cost-Effective L-Tryptophan Production from Indole and L-Serine by E. coli Cells
por: Sadeghiyan-Rizi, Tahereh, et al.
Publicado: (2016)

High-yield vesicle-packaged recombinant protein production from E. coli
por: Eastwood, Tara A., et al.
Publicado: (2023)

Engineering E. coli cell surface in order to develop a one-step purification method for recombinant proteins
por: Fasehee, Hamidreza, et al.
Publicado: (2018)

Expression and purification of truncated diphtheria toxin, DT386, in Escherichia coli: An attempt for production of a new vaccine against diphtheria
por: Shafiee, Fatemeh, et al.
Publicado: (2016)

A universal strategy for high-yield production of soluble and functional clostridial collagenases in E. coli
por: Ducka, Paulina, et al.
Publicado: (2009)

Novel Highly Soluble Chimeric Recombinant Spidroins with High Yield
por: Jia, Qiupin, et al.
Publicado: (2020)

Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli
por: Sørensen, Hans Peter, et al.
Publicado: (2005)

Recombinant Production of a Mutant Form of Soluble IL-6 Receptor with Inhibitory Effects against Interleukin-6
por: Feghhi-najafabadi, Saba, et al.
Publicado: (2022)

Soluble T-cell receptor design influences functional yield in an E. coli chaperone-assisted expression system
por: Gunnarsen, Kristin Støen, et al.
Publicado: (2018)

The Expression of Soluble and Active Recombinant Haemophilus influenzae IgA1 Protease in E. coli
por: Long, Shinong, et al.
Publicado: (2010)

Solubility of recombinant Src homology 2 domains expressed in E. coli can be predicted by TANGO
por: Andersen, Thorny Cecilie Bie, et al.
Publicado: (2014)

Artificial Blood Substitutes: First Steps on the Long Route to Clinical Utility
por: Moradi, Samira, et al.
Publicado: (2016)

The Novel Drug Discovery to Combat COVID-19 by Repressing Important Virus Proteins Involved in Pathogenesis Using Medicinal Herbal Compounds
por: Mahmoudi, Samira, et al.
Publicado: (2021)

Machine learning modeling for solubility prediction of recombinant antibody fragment in four different E. coli strains
por: Hashemi, Atieh, et al.
Publicado: (2022)

Recombinant polypeptide production in E. coli: towards a rational approach to improve the yields of functional proteins
por: de Marco, Ario
Publicado: (2013)

Enhancing Recombinant Protein Yields in the E. coli Periplasm by Combining Signal Peptide and Production Rate Screening
por: Karyolaimos, Alexandros, et al.
Publicado: (2019)

How to find soluble proteins: a comprehensive analysis of alpha/beta hydrolases for recombinant expression in E. coli
por: Koschorreck, Markus, et al.
Publicado: (2005)

Soluble expression, purification, and characterization of active recombinant human tissue plasminogen activator by auto-induction in E. coli
por: Long, Xiaobin, et al.
Publicado: (2015)

Soluble expression of recombinant active cellulase in E.coli using B.subtilis (natto strain) cellulase gene
por: Vadala, Bhuvan Shankar, et al.
Publicado: (2021)

Strategies to Enhance Periplasmic Recombinant Protein Production Yields in Escherichia coli
por: Karyolaimos, Alexandros, et al.
Publicado: (2021)

Synthesis and antimicrobial evaluation of some 2,5 disubstituted 1,3,4-oxadiazole derivatives
por: Jafari, Elham, et al.
Publicado: (2017)

Expressing of Recombinant VEGFR2-specific Nanobody in Baculovirus Expression System
por: Shokrollahi, Narjes, et al.
Publicado: (2021)

In silico design of two novel fusion proteins, p28-IL-24 and p28-M4, targeted to breast cancer cells
por: Ghavimi, Reza, et al.
Publicado: (2020)

Production of soluble eukaryotic recombinant proteins in E. coli is favoured in early log-phase cultures induced at low temperature
por: San-Miguel, Teresa, et al.
Publicado: (2013)

Generation of novel trimeric fragments of human SP-A and SP-D after recombinant soluble expression in E. coli
por: Watson, Alastair, et al.
Publicado: (2020)

High-yield production of functional soluble single-domain antibodies in the cytoplasm of Escherichia coli
por: Zarschler, Kristof, et al.
Publicado: (2013)

Fusion Tag Design Influences Soluble Recombinant Protein Production in Escherichia coli
por: Köppl, Christoph, et al.
Publicado: (2022)

Development of an Anti-HER2 Single-Chain Variable Antibody Fragment Construct for High-Yield Soluble Expression in Escherichia coli and One-Step Chromatographic Purification
por: Byun, Kyu Tae, et al.
Publicado: (2023)

A Robust One-Step Recombineering System for Enterohemorrhagic Escherichia coli
por: Peng, Lang, et al.
Publicado: (2022)

Improved Yield of Recombinant Protein via Flagella Regulator Deletion in Escherichia coli
por: Han, Jae-Ho, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jsrolnhdili0a84305rjrd6fvd